Skip to content

AtriCure ATRC Current maturities of long-term debt

Current maturities of long-term debt at other companies

Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
Artivion logo
ArtivionAORT
ITG
Integer HoldingsITGR

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's current maturities of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's current maturities of long-term debt?
AtriCure (ATRC) reported current maturities of long-term debt of $1.34M in Q1 2026.
How has AtriCure's current maturities of long-term debt changed year-over-year?
AtriCure's current maturities of long-term debt increased by 10.0% year-over-year, from $1.22M to $1.34M.
What is the long-term trend for AtriCure's current maturities of long-term debt?
Over 5 years (2020 to 2025), AtriCure's current maturities of long-term debt has grown at a 9.7% compound annual growth rate (CAGR), from $823K to $1.31M.